ArticleFrontiers in immunology2025
Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Chronic epididymitis threatens male fertility, yet the role of LYG1 in this disease is unclear. LYG1, an immunomodulatory protein, is highly expressed in the mouse epididymis, especially the cauda region prone to fibrosis. This study aimed to explore whether Lyg1 deficiency exacerbates LPS-induced epididymal inflammation, fibrosis and sperm dysfunction. Methods: Sixty-four wild-type (WT) and Lyg1 knockout (KO) mice were divided into four groups. LPS was used to induce chronic epididymitis, with PBS as control. After 42 days, histological staining, flow cytometry, oxidative stress detection, transcriptomic profiling, sperm function analysis and In Vitro Fertilization (IVF) were performed to evaluate related indexes. Results: Under physiological conditions, Lyg1 KO mice had normal reproductive phenotypes. However, LPS-induced inflammation led to more severe epididymal damage, enhanced oxidative stress, abnormal ECM pathways and worse sperm dysfunction (reduced acrosomal integrity and functional proteins) in KO mice. IVF showed a more significant decrease in fertilization rate in KO mice. Discussion: LYG1 regulates the balance between epididymal inflammation and tissue repair. Its deficiency aggravates LPS-induced epididymal fibrosis and sperm dysfunction. This study identifies LYG1-dependent pathways as potential therapeutic targets for chronic epididymitis-related infertility.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.